Article info

Download PDFPDF

Response to: ‘Patients with lupus with COVID-19: University of Michigan experience’ by Wallace et al
Free

Authors

  • Alexis Mathian Sorbonne Université, Assistance Publique–Hôpitaux de Paris, Groupement Hospitalier Pitié–Salpêtrière, French National Referral Center for Systemic Lupus Erythematosus, Antiphospholipid Antibody Syndrome and Other Autoimmune Disorders, Service de Médecine Interne 2, Institut E3M, Inserm UMRS, Centre d’Immunologie et des Maladies Infectieuses (CIMI-Paris), Paris, France PubMed articlesGoogle scholar articles
  • Zahir Amoura Sorbonne Université, Assistance Publique–Hôpitaux de Paris, Groupement Hospitalier Pitié–Salpêtrière, French National Referral Center for Systemic Lupus Erythematosus, Antiphospholipid Antibody Syndrome and Other Autoimmune Disorders, Service de Médecine Interne 2, Institut E3M, Inserm UMRS, Centre d’Immunologie et des Maladies Infectieuses (CIMI-Paris), Paris, France PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Alexis Mathian, Internal Medicine, University Hospital Pitié Salpêtrière, Paris 75651, France; alexis.mathian{at}aphp.fr
View Full Text

Citation

Mathian A, Amoura Z
Response to: ‘Patients with lupus with COVID-19: University of Michigan experience’ by Wallace et al

Publication history

  • Received May 19, 2020
  • Accepted May 20, 2020
  • First published May 31, 2020.
Online issue publication 
February 11, 2021

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.